Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tito Fojo

Showing results (11-20 of 237) with videos related to

Pageof 24
Sort By:
Seminars in Oncology|April 12, 2017
Pseudo-progressing to an unmet needTito Fojo
Seminars in Oncology|June 3, 2023
The flaws in assessing and reporting the toxicities of oral targeted therapies: Everolimus as an exampleTito Fojo
Seminars in Oncology|October 11, 2018
Desperation OncologyTito Fojo
Seminars in Oncology|March 13, 2016
Moving a pioneer journal into the futureTito Fojo
Seminars in Oncology|February 8, 2023
The challenges of selecting cancer medicines for the WHO Essential Medicines List with the elephant in the room: A path forwardTito Fojo
The Oncologist|September 29, 2023
Waiting for ASCO to "Walk the Walk"Tito Fojo
Seminars in Oncology|September 20, 2017
Cancer therapies and the problem of me too manyTito Fojo
Seminars in Oncology|December 20, 2005
Introduction: chemotherapies in the treatment of breast cancerAntonio Tito Fojo
Seminars in Oncology|October 16, 2018
Cuba Sí. Cancer NoAntonio Tito Fojo
Seminars in Oncology|March 9, 2019
Immunotherapy for adrenocortical cancerAntonio Tito Fojo
Pageof 24

Showing results (11-20 of 237) with videos related to

Sort By:
Pageof 24
Seminars in Oncology|April 12, 2017
Pseudo-progressing to an unmet needTito Fojo
Seminars in Oncology|June 3, 2023
The flaws in assessing and reporting the toxicities of oral targeted therapies: Everolimus as an exampleTito Fojo
Seminars in Oncology|October 11, 2018
Desperation OncologyTito Fojo
Seminars in Oncology|March 13, 2016
Moving a pioneer journal into the futureTito Fojo
Seminars in Oncology|February 8, 2023
The challenges of selecting cancer medicines for the WHO Essential Medicines List with the elephant in the room: A path forwardTito Fojo
The Oncologist|September 29, 2023
Waiting for ASCO to "Walk the Walk"Tito Fojo
Seminars in Oncology|September 20, 2017
Cancer therapies and the problem of me too manyTito Fojo
Seminars in Oncology|December 20, 2005
Introduction: chemotherapies in the treatment of breast cancerAntonio Tito Fojo
Seminars in Oncology|October 16, 2018
Cuba Sí. Cancer NoAntonio Tito Fojo
Seminars in Oncology|March 9, 2019
Immunotherapy for adrenocortical cancerAntonio Tito Fojo
Pageof 24